MARKET

STIM

STIM

Neuronetics
NASDAQ
1.280
-0.020
-1.54%
After Hours: 1.330 +0.05 +3.91% 19:54 05/15 EDT
OPEN
1.260
PREV CLOSE
1.300
HIGH
1.360
LOW
1.260
VOLUME
2.49M
TURNOVER
--
52 WEEK HIGH
4.850
52 WEEK LOW
0.8000
MARKET CAP
89.07M
P/E (TTM)
-2.3422
1D
5D
1M
3M
1Y
5Y
1D
Neuronetics Collaborates With ANT Neuro To Expand NeuroStar Advanced Therapy System
Benzinga · 2d ago
NEURONETICS INC - CO AND ANT NEURO PLAN BROADER ROLLOUT OF PARTNERSHIP IN 2ND HALF 2026
Reuters · 2d ago
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
Barchart · 2d ago
Major Investor Makes Bold New Bet on Neuronetics Stock
TipRanks · 2d ago
Neuronetics says Interim PAO Francis X Brown III files initial beneficial ownership statement
PUBT · 2d ago
Neuronetics 10% owner Jorey Chernett buys 475,000 shares for $636,500
PUBT · 3d ago
Weekly Report: what happened at STIM last week (0504-0508)?
Weekly Report · 5d ago
Geopolitical Turmoil and Supply Chain Strains Threaten Neuronetics’ Costs, Margins, and Growth
TipRanks · 05/06 06:02
More
About STIM
Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.

Webull offers Neuronetics Inc stock information, including NASDAQ: STIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STIM stock methods without spending real money on the virtual paper trading platform.